Raymond James Financial
BLFS icon

Raymond James Financial’s BioLife Solutions BLFS Stock Holding History

Raymond James Financial’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.4M Sell
437,732
-6,309
-1% -$147K ﹤0.01% 1971
2026
Q1 		$8.36M Buy
444,041
+3,987
+0.9% +$88.1K ﹤0.01% 2171
2025
Q4 		$10.8M Sell
440,054
-40,384
-8% -$1.06M ﹤0.01% 1904
2025
Q3 		$12.3M Sell
480,438
-228,136
-32% -$5.41M ﹤0.01% 1767
2025
Q2 		$15.3M Sell
708,574
-188,847
-21% -$4.26M 0.01% 1561
2025
Q1 		$20.5M Buy
897,421
+101,423
+13% +$2.67M 0.01% 1290
2024
Q4 		$20.7M Buy
+795,998
New +$19.8M 0.01% 1292

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Raymond James Financial's BLFS Position: Q2 2026 in Review

Raymond James Financial reduced its BioLife Solutions (BLFS) stake by 1.4% in Q2 2026, selling an estimated $147K and leaving 437,732 shares worth $12.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1971.

Raymond James Financial first reported a position in BLFS in Q4 2024 and has held it in 7 quarters since. The position peaked at $20.7M in Q4 2024. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Raymond James Financial held 437,732 shares of BioLife Solutions worth $12.4M as of Q2 2026.
  • Raymond James Financial sold 6,309 BioLife Solutions shares in Q2 2026, an estimated $147K.
  • BioLife Solutions made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #1971 holding.
  • Raymond James Financial first reported a position in BioLife Solutions in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's BioLife Solutions position peaked at $20.7M in Q4 2024.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.